Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 694

1.

CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.

Looi LM, Cheah PL, Zhao W, Ng MH, Yip CH.

Malays J Pathol. 2006 Dec;28(2):83-6.

2.

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.

D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.

Breast Cancer Res Treat. 2007 Mar;101(3):279-84. Epub 2006 Jul 12.

PMID:
16835704
4.
5.

Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?

Saiz E, Toonkel R, Poppiti RJ Jr, Robinson MJ.

Cancer. 1999 May 15;85(10):2206-11. Review.

PMID:
10326699
6.

Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.

Galietta A, Pizzi C, Pettinato G, Limite G, Sgambato A, Lamberti M, Muraro R, Formisano C, Pensabene M, Bianco AR, Mariani-Costantini R, Contegiacomo A.

Oncol Rep. 2002 Jan-Feb;9(1):135-40.

PMID:
11748471
7.

The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.

Yu J, Li G, Li J, Wang Y.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):874-8.

PMID:
15708269
8.

Cellular dyscohesion in fine-needle aspiration of breast carcinoma. Prognostic indicator for axillary lymph node metastases?

Schiller AB, Tadros TS, Birdsong GG, Grossl NA.

Am J Clin Pathol. 2001 Feb;115(2):219-23.

PMID:
11211610
9.

Tumour size as a predictor of axillary node metastases in patients with breast cancer.

Laura S, Coombs NJ, Ung O, Boyages J.

ANZ J Surg. 2006 Nov;76(11):1002-6.

PMID:
17054550
10.

The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.

Li W, Liu F, Lei T, Xu X, Liu B, Cui L, Wei J, Guo X, Lang R, Fan Y, Gu F, Tang P, Zhang X, Fu L.

Pathol Res Pract. 2010 Dec 15;206(12):828-34. doi: 10.1016/j.prp.2010.09.008. Epub 2010 Oct 24.

PMID:
20977976
11.

Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast.

Heatley MK, Ewings P, Odling Smee W, Maxwell P, Toner PG.

Pathology. 2002 Jun;34(3):230-2.

PMID:
12109782
12.

Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.

Berner HS, Suo Z, Risberg B, Villman K, Karlsson MG, Nesland JM.

Histopathology. 2003 Jun;42(6):546-54.

PMID:
12786890
13.

[Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].

Chen JH, Yang YM, Li KZ, Ling R, Yao Q, Yang H.

Ai Zheng. 2005 Apr;24(4):494-7. Chinese.

PMID:
15820077
14.

Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Xie F, Wang Q, Chen Y, Gu Y, Mao H, Zeng W, Zhang X.

Pathol Res Pract. 2010 Nov 15;206(11):735-9. doi: 10.1016/j.prp.2010.05.016. Epub 2010 Jul 15.

PMID:
20634005
15.

A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.

Woo SU, Bae JW, Kim CH, Lee JB, Koo BW.

Ann Surg Oncol. 2008 Jan;15(1):281-5. Epub 2007 Sep 1.

PMID:
17763975
16.

The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.

Koda M, Sulkowska M, Kanczuga-Koda L, Tomaszewski J, Kucharczuk W, Lesniewicz T, Cymek S, Sulkowski S.

Oncol Rep. 2007 Jul;18(1):113-9.

PMID:
17549355
17.

Role of CD44 in nonpalpable T1a and T1b breast cancer.

Lyzak JS, Yaremko ML, Recant W, Baunoch DA, Joseph L.

Hum Pathol. 1997 Jul;28(7):772-8.

PMID:
9224743
18.

[Expressions of survivin and nm23 and the relationship among the expressions and the axillary lymph node metastasis in breast cancer].

Mao J, Hai J, Shu HP, Wu YH, Ou HY, Luo SY, Wang SM.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Jun;30(3):312-4, 334. Chinese.

20.

The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.

Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH.

Int J Surg Pathol. 2007 Apr;15(2):98-109.

PMID:
17478762

Supplemental Content

Support Center